Nisa Investment Advisors, LLC Gritstone Bio, Inc. Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$0.62 - $2.35 $52 - $197	-84 Reduced 73.68%	30 $0
Q1 2024 May 01, 2024	BUY	$1.96 - $2.9 $39 - $58	20 Added 21.28%	114 $0
Q3 2023 Nov 02, 2023	BUY	$1.19 - $2.26 $111 - $212	94 New	94 $0
Q2 2021 Aug 06, 2021	SELL	$8.13 - $10.2 $30,894 - $38,760	-3,800 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$4.07 - $27.11 $15,466 - $103,018	3,800 New	3,800 $36,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.